Open Access25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico City
Author(s) -
Israel Parra-Ortega,
Diana Guadalupe Alcara-Ramírez,
Alma Angélica Ronzón-Ronzón,
Fermín Elías-García,
José Agustín Mata Chapol,
Alejandro Daniel Cervantes-Cote,
Briceida López-Martı́nez,
Miguel Ángel Villasís-Keever,
Jessie Nallely ZuritaCruz
Publication year - 2021
Publication title -
nutrition research and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.506
H-Index - 34
eISSN - 2005-6168
pISSN - 1976-1457
DOI - 10.4162/nrp.2021.15.s1.s32
Subject(s) - medicine , vitamin d deficiency , vitamin d and neurology , observational study , logistic regression , intensive care unit , covid-19 , prospective cohort study , body mass index , univariate analysis , cohort study , multivariate analysis , pediatrics , disease , infectious disease (medical specialty)
Considering the high number of deaths from coronavirus disease 2019 (COVID-19) in Latin American countries, together with multiple factors that increase the prevalence of vitamin D deficiency, we aimed to determine 25-hydroxyvitamin D (25[OH]D) levels and its association with mortality in patients with critical COVID-19.